Cargando…

STAT3 regulation of and by microRNAs in development and disease

MicroRNAs (miRNAs) are endogenously expressed small non-coding RNAs acting at the post-transcriptional level where they promote mRNA degradation and block protein translation. Recent findings suggest that complex transcriptional and post-transcriptional circuits control miRNAs. STAT3 has emerged as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haghikia, Arash, Hoch, Melanie, Stapel, Britta, Hilfiker-Kleiner, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3670237/ https://www.ncbi.nlm.nih.gov/pubmed/24058763 http://dx.doi.org/10.4161/jkst.19573

Ejemplares similares

Data on left ventricular expression of STAT3 and AKT in transgenic mouse models with B16F10 melanoma
por: Pietzsch, Stefan, et al.
Publicado: (2019)

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy
por: Nonhoff, Justus, et al.
Publicado: (2017)

Increased prostaglandin-D(2) in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation
por: Stelling, Elisabeth, et al.
Publicado: (2020)

Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
por: Stapel, Britta, et al.
Publicado: (2017)

Peripartum cardiomyopathy: current management and future perspectives
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2015)

Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
por: Hoch, Melanie, et al.
Publicado: (2011)

Characterization of peripartum cardiomyopathy by cardiovascular magnetic resonance imaging
por: Haghikia, Arash, et al.
Publicado: (2015)

Small molecule-mediated refolding and activation of myosin motor function
por: Radke, Michael B, et al.
Publicado: (2014)

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
por: Boengler, Kerstin, et al.
Publicado: (2010)

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
por: Dutzmann, Jochen, et al.
Publicado: (2015)

MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder
por: Stapel, Britta, et al.
Publicado: (2022)

Regulation of LncRNAs and microRNAs in neuronal development and disease
por: Xuan, Cheng, et al.
Publicado: (2023)

The Role of microRNAs in NK Cell Development and Function
por: Nanbakhsh, Arash, et al.
Publicado: (2021)

MicroRNAs Regulate Bone Development and Regeneration
por: Fang, Sijie, et al.
Publicado: (2015)

MicroRNAs in Development
por: Maatouk, Danielle, et al.
Publicado: (2006)

Two host microRNAs influence WSSV replication via STAT gene regulation
por: Huang, Ying, et al.
Publicado: (2016)

Protective Function of STAT3 in CVB3-Induced Myocarditis
por: Lindner, Diana, et al.
Publicado: (2012)

The Regulation of microRNAs in Alzheimer's Disease
por: Kou, Xianjuan, et al.
Publicado: (2020)

microRNAs: tiny regulators of synapse function in development and disease
por: Bicker, Silvia, et al.
Publicado: (2008)

MicroRNAs as Haematopoiesis Regulators
por: Undi, Ram Babu, et al.
Publicado: (2013)

microRNAs in the Regulation of Melanogenesis
por: Hushcha, Yekatsiaryna, et al.
Publicado: (2021)

MicroRNAs as Regulators of Phagocytosis
por: Gierlikowski, Wojciech, et al.
Publicado: (2022)

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015)

Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study
por: Haghikia, Arash, et al.
Publicado: (2015)

MicroRNAs in mouse development and disease
por: Lewis, Morag A., et al.
Publicado: (2010)

MicroRNAs in kidney development and disease
por: Cerqueira, Débora Malta, et al.
Publicado: (2022)

MicroRNAs: protective regulators for neuron growth and development
por: Ma, Zhi-Xuan, et al.
Publicado: (2022)

MicroRNAs in Cardiac Development
por: Cordes, Kimberly R., et al.
Publicado: (2010)

MicroRNAs in hematopoietic development
por: Montagner, Sara, et al.
Publicado: (2014)

MicroRNAs in skeletal muscle: their role and regulation in development, disease and function
por: Güller, Isabelle, et al.
Publicado: (2010)

Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages
por: Heimerl, Maren, et al.
Publicado: (2020)

The Regulation of Xylem Development by Transcription Factors and Their Upstream MicroRNAs
por: Sun, Pengfang, et al.
Publicado: (2022)

Role of microRNAs in cardiac development and disease
por: Tian, Jing, et al.
Publicado: (2017)

MicroRNAs and the Regulation of Tau Metabolism
por: Hébert, Sébastien S., et al.
Publicado: (2012)

MicroRNAs: regulators of oncogenesis and stemness
por: Papagiannakopoulos, Thales, et al.
Publicado: (2008)

Regulation of Neutrophil Senescence by MicroRNAs
por: Ward, Jon R., et al.
Publicado: (2011)

microRNAs in the Regulation of Adipogenesis and Obesity
por: McGregor, R.A, et al.
Publicado: (2011)

MicroRNAs in the Regulation of MMPs and Metastasis
por: Abba, Mohammed, et al.
Publicado: (2014)

MicroRNAs and the regulation of intestinal homeostasis
por: Runtsch, Marah C., et al.
Publicado: (2014)

MicroRNAs as Novel Regulators of Neuroinflammation
por: Ksiazek-Winiarek, Dominika Justyna, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e9rchnc6bkfm9mq6co9c9tkh6m